Health Care & Life Sciences » Biotechnology | LG Life Sciences Ltd.

LG Life Sciences Ltd. Pfd. Series 1 | Mutual Funds

Mutual Funds that own LG Life Sciences Ltd. Pfd. Series 1

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Matthews Asia Dividend Fund
909,328
11.83%
0
2.34%
06/29/2018
Skagen Kon Tiki
259,179
3.37%
0
1.89%
06/30/2018
Nordea Emerging Market Equities
156,894
2.04%
2,907
1.55%
05/31/2018
Eastspring Asia Oceania High Yield Equity Mother
156,431
2.04%
2,192
0.88%
04/16/2018
Schroder UTL - Asian Income Fund
152,180
1.98%
0
1.63%
05/31/2018
Vanguard Total International Stock Index Fund
91,581
1.19%
0
0.01%
07/31/2018
Schroder Oriental Income Fund Ltd.
86,659
1.12%
0
1.76%
11/30/2017
Matthews Asia Funds - Asia Dividend Fund
69,614
0.91%
0
2.38%
06/30/2018
Candriam Equities L - Emerging Markets
64,000
0.83%
0
0.7%
07/31/2018
iShares Core MSCI Emerging Markets ETF
62,790
0.82%
0
0.02%
09/05/2018

About LG Life Sciences

View Profile
Address
LG Twin Tower
Seoul SL 07336
Korea, Republic Of
Employees -
Website http://www.lgchem.com
Updated 09/14/2018
LG Chem Ltd. manufactures petrochemicals, IT & electronic materials and energy solution materials. It operates through through the following business segments: Petrochemicals, IT & Electronic Materials, Batteries. The Petrochemical division offers naphtha cracking centers and polyolefins, synthetic rubbers and specialty polymers, polyvinyl chloride, acrylonitrile-butadiene-styrene and engineering plastics, acrylates and plasticizers.